Turtle Creek Wealth Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

Turtle Creek Wealth Advisors’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$219K	Hold	2,000	–	–	0.01%	430
2026 Q1	$208K	Buy	+2,000	New	+$213K	0.02%	393

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Turtle Creek Wealth Advisors's PPH Position: Q2 2026 in Review

Turtle Creek Wealth Advisors held its VanEck Pharmaceutical ETF (PPH) position steady in Q2 2026 at 2,000 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #430.

Turtle Creek Wealth Advisors first reported a position in PPH in Q1 2026 and has held it in 2 quarters since. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Turtle Creek Wealth Advisors held 2,000 shares of VanEck Pharmaceutical ETF worth $219K as of Q2 2026.
Turtle Creek Wealth Advisors left its VanEck Pharmaceutical ETF share count unchanged in Q2 2026.
VanEck Pharmaceutical ETF made up 0.01% of Turtle Creek Wealth Advisors's portfolio in Q2 2026, its #430 holding.
Turtle Creek Wealth Advisors first reported a position in VanEck Pharmaceutical ETF in Q1 2026 and has held it in 2 quarters since.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.